Aspiriant, LLC
- SEC CIK
- 0001433541
- Latest filing
- Jul 20, 2026
MET holding history
Metlife Inc in every 13F filed by Aspiriant, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
MET overviewAll 13F holders of METFull Q2 2026 holdings
- Shares (Q2 2026)
- 2,482
- Value
- $210.0K
- % of portfolio
- <0.1%
- Quarters held
- 18
- Since Q1 2022
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 2,482 | $210.0K | <0.1% | −1,542−38.3% | Reduced | Holders |
| Q1 2026 | 4,024 | $284.6K | <0.1% | +599+17.5% | Added | Holders |
| Q4 2025 | 3,425 | $270.4K | <0.1% | +214+6.7% | Added | Holders |
| Q3 2025 | 3,211 | $264.5K | <0.1% | −655−16.9% | Reduced | Holders |
| Q2 2025 | 3,866 | $310.9K | <0.1% | +530+15.9% | Added | Holders |
| Q1 2025 | 3,336 | $267.8K | <0.1% | +115+3.6% | Added | Holders |
| Q4 2024 | 3,221 | $263.7K | <0.1% | +3+0.1% | Added | Holders |
| Q3 2024 | 3,218 | $265.4K | <0.1% | +17+0.5% | Added | Holders |
| Q2 2024 | 3,201 | $224.7K | <0.1% | −1,095−25.5% | Reduced | Holders |
| Q1 2024 | 4,296 | $318.4K | <0.1% | +88+2.1% | Added | Holders |
| Q4 2023 | 4,208 | $278.3K | <0.1% | +95+2.3% | Added | Holders |
| Q3 2023 | 4,113 | $258.7K | <0.1% | +297+7.8% | Added | Holders |
| Q2 2023 | 3,816 | $215.7K | <0.1% | −26−0.7% | Reduced | Holders |
| Q1 2023 | 3,842 | $222.6K | <0.1% | +98+2.6% | Added | Holders |
| Q4 2022 | 3,744 | $271.0K | <0.1% | +243+6.9% | Added | Holders |
| Q3 2022 | 3,501 | $213.0K | <0.1% | +113+3.3% | Added | Holders |
| Q2 2022 | 3,388 | $213.0K | <0.1% | +42+1.3% | Added | Holders |
| Q1 2022 | 3,346 | $235.0K | <0.1% | +3,346 | New | Holders |